Population Pharmacokinetics of Inotuzumab Ozogamicin in Pediatric Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia: Results of Study ITCC-059
Jen-Hao Wu(Princess Máxima Center), Alwin D. R. Huitema(The Netherlands Cancer Institute), Inge M. van der Sluis(Princess Máxima Center), C. Michel Zwaan(Hôpital Saint-Michel), Franco Locatelli(Bambino Gesù Children's Hospital), Susana Rives(Hospital Sant Joan de Déu Barcelona), Fanny Rialland(Hôpital Mère-Enfant), Christiane Chen‐Santel(Universitätsmedizin Rostock), Gernot Engstler(St Anna Children's Hospital), Jan Starý(Charles University), Anneke C. J. Ammerlaan(Princess Máxima Center), Arnaud Petit(Sorbonne Université), Uta Dirksen(Essen University Hospital), Kei Fukuhara(Pfizer (Japan)), Geneviève Plat(Centre Hospitalier Universitaire de Toulouse), Francisco Bautista(Princess Máxima Center), Carmelo Rizzari(Hôpital Saint-Michel), Cristina Díaz de Heredia(Universitat Autònoma de Barcelona), Edoardo Pennesi(Princess Máxima Center), Erica Brivio(Princess Máxima Center), Lucie Šrámková(University Hospital in Motol), Bella Bielorai, May Garrett(Pfizer (United States)), Alba Rubio‐San‐Simón(Hospital del Niño), Aengus O’Marcaigh(Children's Health Ireland at Crumlin), Karsten Nysom(Copenhagen University Hospital), Yves Bertrand(Université Claude Bernard Lyon 1), Benoît Brethon(Hôpital Saint-Louis), Bénedicte Bruno(Centre Hospitalier Universitaire de Lille), Claudia Rössig(Klinik und Poliklinik für Kinder- und Jugendmedizin)
Cited by 6
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study
|The Lancet Respiratory Medicine|2020|738
B cell–helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen
|Nature Immunology|2011|724